FindTrial
Sign In

Stool CBNAAT Test for Pediatric Abdominal Tuberculosis

Stool CBNAAT (Cartridge-Based Nucleic Acid Amplification Test) in Pediatric Abdominal Tuberculosis: A Pilot Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052525
Enrollment
30
Registered
2023-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 6m- 18 years Patients with CECT-diagnosed abdominal tuberculosis who are planned to be initiated on ATT (Antitubercular therapy)

Exclusion criteria

Exclusion criteria: • Patients who have already been started on treatment for tuberculosis. • Patients with other gastrointestinal infections that could mimic similar symptoms

Design outcomes

Primary

MeasureTime frame
To determine the predictive value of stool CBNAAT for diagnosis of abdominal tuberculosis.Timepoint: 12 months—

Secondary

MeasureTime frame
Correlation between stool CBNAAT and CECT abdomen in children with abdominal tuberculosis. Correlation between stool CBNAAT and stool LJ medium for abdominal tuberculosis. Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr MADHU SUDAN

UNIVERSITY COLLEGE OF MEDICAL SCIENCES

manish_2710@yahoo.com9811036569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026